These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8092834)

  • 21. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
    Klepser ME; Wolfe EJ; Jones RN; Nightingale CH; Pfaller MA
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1392-5. PubMed ID: 9174207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid flow cytometric susceptibility testing of Candida albicans.
    Ramani R; Ramani A; Wong SJ
    J Clin Microbiol; 1997 Sep; 35(9):2320-4. PubMed ID: 9276410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
    Ernst EJ; Yodoi K; Roling EE; Klepser ME
    Antimicrob Agents Chemother; 2002 Feb; 46(2):578-81. PubMed ID: 11796383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1996 May; 40(5):1277-9. PubMed ID: 8723483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC; Chang JJ; Huang AH; Chang TC
    J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C; Goudard M; Blancard A; Quilici M; Regli P
    Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
    Burgess DS; Hastings RW; Summers KK; Hardin TC; Rinaldi MG
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):13-8. PubMed ID: 10744363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
    Kaspar RL; Drutz DJ
    Antimicrob Agents Chemother; 1975 Apr; 7(4):462-5. PubMed ID: 1096801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK; Pankiewicz IJ
    Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
    Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW
    Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
    Ponce E; Pechère JC
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.
    Minguez F; Chiu ML; Lima JE; Nique R; Prieto J
    J Antimicrob Chemother; 1994 Jul; 34(1):93-100. PubMed ID: 7961220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.